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Abstract 
This final year research project is about the detection of Streptococcus bovis (S. bovis) in 
hospitalized patients that suffers from inflammatory bowel disease or colonic carcinoma. From 
50 samples collected from patients, one have been positively identified for S.bovis. From Chi-
square analysis, it has been determined that there is no significant association between the 
presence of Streptococcus bovis species and the age, sex and the type of disease of hospitalized 
patients at HUSM. There is possible association between the race of patients and presence of 
the bacteri . Several factors regarding patients conditio~ validity of the sample and collecting 
and processing method have been identify as reasons why such results have been achieved. 
Abstrak 
Projek penyelidikan tahun akbir ini adalah mengenai pengesanan bacteria Streptococcus 
bovis dalam pesakit di hospital yang mengidap penyakit radang usus besar k:ronik atau 
barah usus. Dari 50 sampel yang diambil dari pesakit, satu adalah positif untuk S. bovis. 
Kesimpulan yang. diperolehi ialah tiada hubungkait diantara kehadiran bacteria S. bovis 
dengan umur, jantina dan jenis penyakit yang dihidapi oleh peakit HUSM. Terdapat 
kemungkinan hubungkait di antara kaum dan kehadiran bakteria tersebut. Beberapa. faktor 
yang perlu diambil kira adalah keadaan pesakit cam mengumpul dan memproses dan 
kesahihan sampel. Faktor-faktor ini mungkin memberi kesan ke atas keputusan yang 
diperolebi. 
1. Introduction 
This dissertation is prepared as a partial fulfillment for the Bachelor of Health Science 
in Biomedicine. This project concerns about the detection of Streptococcus bovis (S. bovis) 
in hospitalized patients with inflammatory bowel disease (ffiD) and colonic carcinoma. 
Research on detection of S. bovis in hospital settings had been perfonned by Klein et.al. 
( 1977) and the results concluded that there are significant levels of S. bovis in mo or colon 
cancer patients fecal isolates. Jean et.al. (2003) indicated that S.bovis is present in many 
types of mo and not concentrated on a specific type of bowel disease. Waisberg et.al. 
(2002) indicated that many studies have warned of the need for investigation of colonic 
lesions among patients, especially elderly ones, who have bacteraemia and/or endocarditis 
from S. bovis. The common knowledge is that there is an association between S. bovisand 
carcinoma of the colon and this could have important clinical implications for early 
detection of the lesion (Leport et.al. ,1987). In contrast, Norfleet and Mitchell (1993) and 
Potter et.al. (1998) reported that there seems to be no clear association between S. bovis 
and human co1orecta1 carcinoma. Other studies concerning S. bovis have been about trying 
to find association between the bacteria and colonic carcinoma. To date, there have been no 
conclusive evidence on whether the S. bovis directly causes colonic carcinoma or if s 
presence is a marker for bowel disease (Sinave, 2001 ). 
Currently, there is no research conducted on detection of S. bovis from hospitalized patients 
with mD and colonic carcinoma in HUSM This study could prove vital in understanding 
the scope of this problem in HUSM. 
1 
1.2 Objectives 
There are two main objectives for this project. First objective is to obtain and isolate S. 
bovis from fecal culture of samples from hospitalized patients. The second, positive tests 
will be tabulated using statistical analysis and any relationship between the carrier state, 
sex, age and race will be determined. This study will be used to compare whether the 
presence of S. hovis in hospitalized patients will be as significant as studies done 
previously. 
2. Literature Review 
2.1 Characteristics of Streptococcus bovis 
It is important to understand the general characteristics of S. bovis before any research can 
be perfonned in order to differentiate the bacteria from the rest of the species. S. bovis is a 
non beta-haemolytic gram positive-cocci in chains (figure 2.1 ). Previous studies indicated 
that s. bovis is a bacterium that can be found in cattle ruminaries (Skinner and Quensel, 
1978). It is a normal inhabitant of cattle, but it might be transmitted to humans through 
contaminated milk or food. Recent studies sti11 unable to find the proper mode of 
transmission of the bacteria from cows to human. What have been detennined is that S. 
bovis causes 24% of all infective endocarditis cases (Songy et.al. , 2002) . 
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S. bovis is a streptococcal group D bacteria (table 2.1). It have typeD lipotechoic acid 
antigen on its outer cell wall. S. bovis also accounts for the majority of group D bacteria in 
human (Moellering et.al., 1974). The other types , S equinea and S. alactolyticus are only 
present in animal's gut system (Forbes et.a/.,1998). There are two distinctive biotypes of S. 
bovis which areS. bovis I andS. bovis TI (Farrow et.a/.,1984). S. bovis TI can also be further 
divided to subtypes lli1, which mostly affected endocardium region, and W2 which usually 
isolated from bowel, urinary tract or biliazy tract of patients (Collier et.a/.,1998). This study 
will concentrate to the whole S. bovis bacteria. and not trying to identify each specific 
biotypes. Groves (1997) indicated that S. bovis share other properties in common with other 
enterococci including their ability to grow in 40% of bile and to hydrolyze esculin. Growth 
in 6.5% Sodium Chloride (NaCI) or the pyrrolidonyl arylamidase (PYR) reaction can help 
in differentiating S. bovis from enterococci or viridian streptococci (Parker and Duerden, 
1990). 
2. 1 Figure of S. bovis in Blood Agar Media 
(reproduced from www.qfever.com) 
3 






























(reproduced from http://gsbs.utmb.edu/microbook/ch013.htm) 
2.2 Characteristics of the patients 
Patients that are suitable for this project are those who are suffering from any type of 
inflammatory bowel disease or colonic carcinoma. Other types of patients that can be taken 
under considemtions are those who are being treated for urinary tract infections, 
miscellaneous infections and bacteraemias. Patients from USM hospital will be asked to 
participate in this research. 50 patients will be determined and must agree to participate in 
the study. The patients will be picked randomly regardless of race, sex and age. This is in 
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order to get samples that are valid for this study and can be represented to the whole 
populatiolL The patients must be able to defecate in order to obtain sample for isolation and 
identification. This is because the bacteria usually resides in large bowel of human. 
Patient's family members or guardians and HUSM staffs will informed if the sample need 
to be collected from patients who are incapable or debilitated. 
Sinave (200 1) found out that there is no significance differences in sex, race and 
geographical background for patients with S. bovis in their system. The bacteria is usually 
found in greater number in older patients with underlying colonic carcinoma and 
inflammatory bowel disease. Human factors such as patient's co-operation, difficulty in 
defecating and validity of collected sample needs to be addressed before any sample is 
taken. This will ensure that valid sample with patient's consent is taken for testing. 
Streptococcus bovis is the main human pathogen among nonenterococcal group D 
streptococci. S. bovis is a well-documented cause of infective endocarditis (Ellen 
et.a/,1990). The organisms were isolated more frequently from stools of patients with 01 
malignancies. It is unclear whether S. bovis plays a causative role in colon cancers or is 
only as a marker of the disease. There is no variation occurs among different geographical 
areas, race and sex. Nearly all patients with S. bovis are older than SO years (Sinave, 2001). 
Streptococcus bovis is a bacterium normally found in the rumen of ruminant animals such 
as cattle and sheep. S. hovis is also rarely isolated from humans but was reported to cause 
such disease as endocarditis and meningitis. Recent reports also suggest a correlation 
between increased levels of S. bovis and human colonic cancer. Differences in biochemical 
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characteristics between human and ruminal strains of S. bovis contribute to difficulties of 
identifying human isolates of the bacteria (Whitehead, 1999). 
The association of Streptococcus bovis endocarditis with colonic neoplasia can be 
described and exceeds 50%. The prevalence of S. bovis in fecal cultures from patients with 
carcinoma of the colon is significantly increased (56%) as compared to controls (10%) and 
also patients with ffiD (28%) (Zabiela et.al., 2002) 
Streptococcus bovis causes 24% of all streptococcal infective endocarditis cases from his 
studies of clinical isolates: The research also indicated that there are reports linking the 
presence of S. bovis bacterae.mia and endocarditis with various forms of gastrointestinal 
disease, primarily colonic cancers. The research also found out that S. bovis biotype I strain 
is much more frequently isolated in cases of gastrointestinal disease (Songy , 2002). 
It is not clear whether S. bovis plays an etiological role in carcinoma of the colon or is 
merely marker for the disease. Several studies have shown that increase in stool carriage 
in patients with malignant or premalignant lesion of the colon as compared with normal 
subjects from whom S. bovis is rarely isolated in stool cultures (Groves, 1997). 
There is the need for investigation of colonic lesion among older patients, who have 
bacteraemia and/or endocarditis from Streptococcus bovis. Bacteraemia and infective 
endocarditis from endocarditis may be related to the neoplastic lesions in the large 
intestine. This report described patients who presented infective endocarditis from S. bovis 
associated with colonic carcinoma and tubular-villous carcinoma. The knowledge is that 
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there is an association between endocarditis from S. bovis and carcinoma of the colon has 
important clinical implications (Waisberg et.al., 2002). 
There is possible association between colonic adenocarcinoma and S. bovis endocarditis. 
Non-enterococcal Group D streptococci were isolated from fecal cultures of 11 of 1 OS 
controls, 35 of63 patients with carcinoma of the colon, 7 of25 with IBD, 4 of21 with non-
colonic neoplasms and 5 of 37 with GI disorders. The presence of S. bovis in fecal cultures 
from patients with carcinoma of the colon was significantly increased (P<O.OOl) as 
compared to those in controls, and also to all the other groups (P<0.001). Patients with 
inflammatory bowel disease were more frequently carriers. The carrier state was related to 
age, hospitalization status, colonic stasis, gastrointestinal bleeding or recent examination. 
The implications of this associations are unknown (Klein et.al., 1977). 
A prospective analysis of patients with S. bovis septicaemia had documented the presence 
of gastrointestinal lesion. 29 patients were studied and 15 of those undergone 
gastrointestinal evaluation. Two out of fifteen patients have GI neoplasms in the colon. 
This lesion ranged from adenomatous polyps to adenocarcinomas. From this report, it was 
suggested that patients with S. bovis septicaemia undergoes thorough investigation of the 
GI tract even in the absence of the symptoms (Klein et.al., 1979). 
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J. Materials and Methods 
J.l Materials 
3.1.1 Patient's sample collection 
I. Questwnnaires and Consent forms 
ll. Patient's fecal sample {50 samples) 
Criteria for fecal .sample: 
0 Patients are diagnosed with IBD or colonie carcinoma. 
[J Patients are not under medication prior to sample .collection. 
0 Sample must be processed within 2 hours of collection. 
ill. Transport media (normal oollecting bottle) 
3.1.2 Patient's sample isolation 
1. Blood Agar media {enriclnnent media) 
2. MacConkey agar media {differential media) 
3.1.3 Patient's sample identificaticm 
1. Optochin disks 
2. Bile solubility test 
J. Bile-esoolin reaction 
4. Growth in 6.5% NaCl 
S. PYR {pyrrolidonylarylamidase reaction) 
6. ESC {hydrolysis of esculin) 
7. VP (Voges-Proskauer reaction) 
8. Sugar broths : Mannitol , Melibiose , Sorbitol , Trehalose 
9. New Strept grouping kit from Oxoid 
3.1.4 Statistical analysis 
SPSS software will be used to perform statistical analysis from the results of the 
studies. 
3.2Methods 
3.2.1 Samples collection 
Fifty fecal samples (25 samples from male and 25 samples from female) were collected 
from patients suffering from inflammatory bowel disease or colonic carcinoma are 
identified. The patients are briefed with informed consent regarding the procedure 
and must agree to participate in the study. The patients are required to answer 
questionnaire concerning their conditions. The patients will be provid~ with specimen 
collecting bottle. The patients is asked to fill the collecting bottle with their stool 
with assistant from their guardians or HUSM staff. The fecal sample will be collected 
and sent to Microbiology Department Laboratory for identification and processing. The 
sample must be processed within two hours after sample collection. 
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3.2.2 Samples isolation 
Each sample collected was streaked on Blood Agar media (BA) and MacConkey Agar 
media (Mac). The plates were incubated at 37°C overnight. Each plate is observed for 
colony appearance. The appearance of S. bovis is small, smooth, mucoid colony and non-
haemolytic. Gram stain is performed on a slide using colony from the BA media.. 
Microscopic appearance of Gram positive cocci in chains is an indication of presence of 
streptococcus species in the sample. Biochemical test needs to be performed in order to 
confmn the presence of S. bovis from the samples collected 
3.2.3 Samples identification 
Several biochemical test can be use to indicate the presence of S. bovis in the sample . 
These tests helped in differentiate S. bovis from other pathogen. 
3.2.3.1 Optochin disks 
This test is used to determine the effect of optochin ( ethylhydrocupreine hydrochloride) on 
an organism. Optocbin disks is placed on the streaked area of suspected colonies on BA. 
Incubate the plate for 18-24 hours at 35-37'c in 5% C02. Zone of inhibition (14mm) is 
measured. Optochin lyses pneumococci (positive test) but alpha-streptococci are resistant. 
The colony should remain intact for this test. 
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3.2.3.2 Bile solubility Test 
Bile solubility test differentiate S. pneumoniae (positive) and alpha-haemolytic streptococci 
(negative). Bile or solution of bile salt, such as sodium desoxycholate lyses pneumococcal 
colonies. One or two drops of bile salts is placed on isolated colony on BA. Gently wash 
liquid over colony and incubate the plate at 35°c for 30 minutes. Lysis of colony is 
examined. 
3.2.3.3 Bile Esculin Reaction 
Gram positive bacteria other than group D streptococci and enterococci are inhibited by the 
bile in this medium. Group D streptococci can grow in the presence of 40% bile and 
hydrolyze esculin. They will turn the indicator, ferric ammonium citrate, a dark brown 
colour. One or two colonies from overnight culture is inoculated onto the surface of the 
slant Incubate at 35° for 48 hours. Blackening of the agar slant will occur for positive 
results. 
3.2.3.4 Growth in 6.5% NaCI 
This test is used to detennine the ability of an organism to grow in high concentration of 
salt. It is used to differentiate enterococci (positive) from nonenterococci (negative). The 
broth contain a small amount of glucose and bromcresol purple as the indicator for acid 
production. Colony from overnight culture is inoculated into 6.5% NaCI broth. Incubate 
overnight and check daily for growth. No turbidity and no colour change for S. bovis. 
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Pyrrolidonylarylamidase reaction (PYR), Hydrolysis of Esculin (ESC), Voges-Proskauer 
Reaction (VP), Sugar Broths and Strept grouping kit is not performed for this study. The 
use of Optochin disks reaction, bile esculin agar, bile solubility test and growth in 6.5% 
NaCl are adequate in order to identify the presence of S. bovis in fecal samples isolates . 
3.2.4 Statistical analysis 
The results collected from patients sample were tabulated. Statistical analysis were used to 
determine whether there is significance between the patients status and age, sex, race and 
hospitalization status. Chi-square (X2) analysis of the linkage was used to identify 
association between S. bovis and the parameters of age, sex, race and types of diseases. 
SPSS software was used for this analysi~. 
3.2.4.1 Calculation method for Chi-square (12) analysis of the linkage 
Xa analysis for the linkage between detection of Streptococcus 
bovis and the parameters 
1) Hypothesis 
no- There is an association between the parameters and detection of S.bovil; 
HA _There is no association between the parameters and detection of S. bovis 
2) Level of significance 
12 
Level of significance is set at a === 0.05 
3) Assumption 
i) Data is independent 
ii) Expected freq~ency (EF) = 0 
(EF) < 5 ::; 20% of the cells -+ 'f' 
4) Statistical test 
A 
B 
0 = Observed outcome 











Degree of freedom (Do F) = ( r- 1) ( c- 1) 
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r =Total number of rows 
c = Total number of columns 
X,2 calculated (P) 
(a-E)2 
a+b 
+ (c-E)2 + 
c+d 
P= 
X: tabulated ( a l 
DoF = ( r - 1) ( c-1) = 
(b-E)2 + (d-E)2 
a+b c+d 
a= (X2 critiatl values at level of signifieanc~ 0.05) 
5) Interpretation 
x2 calculated ' p = --~ fall in rejection zone or acceptance zone 
X2 tabulated' a= -
x2 cal > x:z, tab ~ reject null hypothesis at p ~ 0.05 
r tab > X2 cal-+ accept null hypothesis at p ~ 0.05 
6) Conclusion 
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ll There is an association between presence of S. bovis and parameters 
A There is no associati~n between presence of S. bovis and parameters 
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4.1 Results 
The results of this study are summarized in table 4.1, which shows two cases of colonic 
carcinoma and twenty-three cases of mo in male patients. Table 4.2 shows presence of 
colon cancer in two female patients and twenty-three cases ofiBD. Table 4.3 indicates four 
samples that are positive for pure streptococcus species in male patients. Table 4.4 shows 3 
samples that are positive for streptococcus in female patients. Seven samples in total are 
positive for streptococcus species. The seven samples were isolated and biochemical test 
performed on each sample. One sample was identified as positive for Streptococcus bovis 
from the biochemical test (Table 4.5) 
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Table 4.1 Male samples collected for isolation 
No Reg. no. Sex Age 
I B5 M <50 
2 B257983 M <50 
3 B261960 M <50 
4 B262691 M <50 
5 B062847 M <50 
6 B8 M <50 
7 4277279 M <50 
8 B3 M <50 
9 B262587 M <50 
10 B13 M <50 
II B16 M <50 
12 Bl5 M <50 
13 B258352 M >50 
14 B263363 M >50 
15 B259385 M >50 
16 B17 M >50 
17 B14 M >50 
18 B254691 M >50 
19 B258084 M >50 
20 A122122 M >50 
21 B262330 M >50 
22 B262346 M >50 
23 B6 M >50 
24 B7 M >50 
25 B085956 M >50 
Age: <50= under the 50 years of age 
>50 = over the SO yean of age 
Race: M = Malay 


























c Colonic carcinoma 
c IBD 
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Table 4.2 Female samples collected for isolation 
No Reg. no. 
! 
26 Al58937 F 
27 A014463 F 
28 B175620 F 
29 A158937 F 
30 B209630 F 
31 B-188778 F 
32 B165603 F 
33 B242345 F 
34 B236189 F 
35 B259539 F 
36 B262729 F 
37 A168947 F 
38 B880144 F 
39 A837797 F 
40 B217259 F 
41 B259529 F 
42 A066498 F 
43 B045767 F 
44 B8259SI9 F 
45 A056l98 F 
46 B258352 F 
47 A026285 F 
48 A885000 F 
49 A009482 F 
50 B023659 F 
Age: <SO =under the 50 years of age 
>50 =over the 50 years ,of age 
Race: M ~ Malay 
I= Indian 
C = ChineSe 























































Table 4.3 Results of plate culture for male samples 
No Reg. no. Plate cultures Gram stain 
1 BS Mixed growth G-ve bacilli 
2 B257983 Small , pin-point 
3 B261960 Beta - haemolytic 
4 B262691 Beta - haemolytic 
5 B062847 Beta-haemolytic 
6 B8 Beta - haemolytic 
7 4277279 Small colony G+ve 
diplococci 
8 B3 Mixed growth G-ve bacilli 
9 B262587 Beta -haemolytic 
10 B13 Smooth , cream G+ve 
colour streptoeocci 
11 B16 Beta -haemolytic 
12 B15 Beta - haemolytic 
13 B258352 Mixed growth G-ve bacilli 
14 B263363 Smooth , cream G+ve 
colour staphylococci 
15 B259385 Smooth , cream G+ve 
colour streptococci 
16 Bl7 Smooth colony 
17 B14 Beta-haemolytic 
18 B254691 Beta-haemolytic 
19 B258084 Beta - haemolytic 
20 Al22122 Smooth ,cream G+ve 
colour staphylococci 
21 B262330 No growth 
(salmonella?) 
22 B262346 Smootli , cream G+ve 
colony streptococci 
23 B6 Beta - haemolytic 
24 B7 Smooth , cream G+ve 
colour streptococci 
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Table 4.3 (continued) 
I B085956 I Small colony IG+ve 
diplococci 
Table 4.4 Results of plate cultures for female samples 
No Reg. no. Plate cultures Gram stain 
26 Al58937 Mixed growth G-ve bacilli 
27 A014463 Smooth ,cream G+ve 
colony staphylococci 
28 B175620 Smooth , cream G+ve 
colony staphylococci 
29 A158937 Beta -haemolytic 
30 B209630 Beta - haemolytic 
31 B188778 Beta - haemolytic 
32 B165603 Smooth , cream G+ve 
colony staphylococci 
33 B242345 Mixed growth G-ve bacilli 
34 B236189 Mixed growth G-ve bacilli 
35 B259539 Beta - haemolytic 
36 B262729 Mixed growth G-ve bacilli 
37 A168947 Beta - haemolytic 
38 B880144 Smooth cream G+ve 
colony streptococci 
39 A837797 Beta - haemolytic 
40 B217259 Beta - haemolytic 
41 B259529 Smooth cream G+ve 
colony streptococci 
42 A066498 Beta - haemolytic 
43 B045767 Mixed growth . G-ve bacilli 
44 B8259519 Mixed growth G-ve bacilli 
45 A056198 Smooth , cream G+ve 
colony staphylococci 
46 B258352 Not significant 
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Table·4.4 (continued) 
47 A026285 13eta-haeDnol~c 
48 A885000 Smooth , cream G+ve 
colony streptococci 
49 A009482 Beta-haemolytic 
50 B023659 Small-pinpoint 
colony 
Table 4.5 Results of biochemical testing on positive samples of 
Streptococcus species 
No Reg. no Optocbin Blle Bile 6.5% 
disks solubility esculin NaCI 
Reaction · 
10 B13 Resistant Negative Negative 
15 B259385 Resistant Negative Negative 
22 B262346 Resistant Negative Negative 
24 B7* Resistant Negative Positive Negative 
38 B880144 Resistant Negative Negative 
41 B259529 Resistant Negative Positive Positive 
48 A885000 Resistant Negative Negative 
* Sample positive for S. bovis 
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It had been determined in the Table 4.5 that patients with the registration number B7 was 
positive for Streptococcus bovis species. This was determined by biochemical testing that 
indicated the presence of group D streptococci in the patient's stool sample . 
4.2 Statistical Analysis 
The statistical analysis is performed in order to verify whether there was significant 
presence of Streptococcus bovis species in hospitalized patients in HUSM . Chi - square 
analysis will be performed on the positive sample against the age (4.6.1), sex (4.6.2), 
diseases (4.6.3) and races (4.6.4) of the patients. Calculations for 4.6.1 , 4.6.2, 4.6.3 and 
4.6.4 can be viewed in Appendix D 
4.2.1 Chi-square (Xl) analysis for the linkage between detection of Streptococcus bovis and 
the age of patients 
A There is no association between the presence of Streptococcus bovisand the age of patients 
4.2.2 12 analysis for the linkage between detection of Streptococcus bovis and the sex of 
patients 
A There is no association between the presence of Streptococcut~ bovill and the age of patients 
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4.6.3 X2 analysis for the linkage between detection of Streptococcus bovisand the disease of 
patients 
A There is no association between the presence of Streptococcus bovis and the disease of 
patients 
4.6.4 1! analysis for the linkage between detection of Streptococcus bovis and the race of 
patients 




5.1 Discussion on collection and processing of samples 
All the SO samples obtained from the patients were collected and processed in 
Microbiology Laboratory in Pusat Pengajian Sains Perubatan (PPSP). After culturing the 
samples, seven samples have been identified as Streptococcu() species. The other samples 
were tested negative for Streptococcus species. The seven positive samples was tested 
using biochemical test. The results indicated that only one sample tested positive for 
presence of Streptococcus bovis. The positive sample came from a Chinese patient 
suffering from colonic carcinoma. 
The study showed that one of four (25%) patients with colonic carcinoma and none out of 
forty- six samples from IBD patients are positive for S.bovis. This shows that 4% of all 
samples collected is positive for the bacteria. Further breakdown shows that none of the 
samples from Malay patients ( 0 in 46), one in three Chinese patients (33%) and none in 
Indian patient (0 in 1) is positive for S. bovis. The bacteria is present in 1 of 25 male 
samples ( 4%) and none in 25 female samples. There is no presence of this bacteria in 21 
patients under 50 years old and 1 in 29 (3.5%) patients over 50 years old. Klein et.al. 
( 1977) found out that 56% patients with colonic carcinoma and 28% with mo had s. bovis 
in their system. Similar studies by Zabiela et.al. (2002) shows that prevalence of S. bovis 
from fecal culture in colonic carcinoma patients usually exceeds 50% and 28% positive 
results in patients with IBD. Several other studies also reported similar numbers in their 
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